OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239) - Archive ouverte HAL Access content directly
Conference Papers Retrovirology Year : 2009

OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239)

(1, 2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (11) , (11) , (11) , (1, 12)
1
2
3
4
5
6
7
8
9
10
11
12

Abstract

n.A

Domains

Life Sciences [q-bio] Human health and pathology Infectious diseases
Fichier principal
Vignette du fichier
1742-4690-6-S3-O29.pdf (136.76 Ko) Télécharger le fichier
Vignette du fichier
1742-4690-6-S3-O29.xml (7.51 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00663579

Submitted on : Friday, January 27, 2012-1:18:46 PM

Last modification on : Monday, July 20, 2020-12:34:51 PM

Long-term archiving on: Saturday, April 28, 2012-2:26:22 AM

Download

Dates and versions

inserm-00663579 , version 1 (27-01-2012)

Identifiers

Cite

Jean-Pierre Routy, Mohamed-Rachid Boulassel, Mona Loutfy, Sylvie Vézina, Cécile Tremblay, et al.. OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239). AIDS Vaccine 2009, Oct 2009, Paris, France. pp.O29, ⟨10.1186/1742-4690-6-S3-O29⟩. ⟨inserm-00663579⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM
125 View
116 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More